KBL Merger Corp IV (KBLMU)
|52 Week Range||7.62-14.52|
|1y Target Est||-|
|Debt / Equity||38.31%||Neutral|
Upgrades & Downgrades
In Pursuit of the Elusive Drug — the Billion-Dollar Blockbuster - NetworkNewsWire
NetworkNewsWire Editorial Coverage: Enormous amounts of money exchange hands in the big pharma space as companies merge and are acquired — all in search of the next blockbuster drug. While the discovery of a blockbuster drug, or a drug that generates... ...
Banking on the Next Blockbuster Drug - NetworkNewsWire
NetworkNewsWire Editorial Coverage: Pharmaceutical companies invest enormous amounts of time and money on the research and development of new drugs, typically years in the making and costing millions of dollars. Only occasionally is a new drug develo... ...
180 Life Sciences Corp. Expands IP Portfolio with EU, U.S., and Chinese Patents - NetworkNewsWire
The company’s patent portfolio includes its own intellectual property and exclusive worldwide licenses, including in the U.S., Canada, Europe, Australia, Hong Kong, and China 180 Life Sciences is in the final stages of its merger process with KBL Mer... ...
SPACs Surge as Biotech Booms - NetworkNewsWire
NetworkNewsWire Editorial Coverage: As the world has focused on the search for COVID vaccines and therapeutics, biotech IPOs have quietly gone bonkers. As a matter of fact, 2020 is on track to post the highest number of biotech IPOs in over five year... ...
Blockbuster Year and Bright Horizons for SPACs - NetworkNewsWire
NetworkNewsWire Editorial Coverage: The year 2020 has already seen 127 SPAC IPOs, which have collectively raised over $48.5 billion in proceeds — more than the past ten years combined. A special purpose acquisition company (SPAC) is essentially a bla... ...
Life-Saving Advancements, Treatments Delivered by Companies Invested in Innovation - NetworkNewsWire
NetworkNewsWire Editorial Coverage: Innovation and breakthroughs in the biotech industry are essential to identifying and providing life-saving treatments. Companies that invest substantial amounts of time, effort, and resources in key areas of resea... ...
Solving One of the Largest Drivers of Disease: Inflammation - NetworkNewsWire
NetworkNewsWire Editorial Coverage: Inflammation typically occurs in the body as a natural response to threats such as infection or injury, but chronic inflammation can cause severe damage and even death. Inflammation is a well-known symptom of multi... ...
KBL Merger Corp. IV (NASDAQ: KBLM) Fulfilling IPO Goal Through Merger With 180 Life Sciences Corp. -...
KBL Merger Corp. IV is set to finalize the acquisition of 180 Life Sciences Corp. during Q4 2020 180 Life Sciences Corp. has several ongoing programs at different stages of development, with the leading candidate in Phase 2b/3, helping mitigate the r... ...
Sebi pulls up Kirloskar’s promoters for fraud
In a showcause notice to the six promoters of KBL and two others, Sebi alleged that the promoter group was aware of the precarious financial condition of KBL when these shares were sold, committing a fraud on minority shareholders of Kirloskar Indust... ...
3 SPACs Score - CCXX, SPAQ, & HYAC
SPAC Winners And Losers. SPAC Size Matters. ...